Treatment for the Mental Health Impact of Killing in War
|ClinicalTrials.gov Identifier: NCT01406834|
Recruitment Status : Completed
First Posted : August 1, 2011
Last Update Posted : August 18, 2014
The goal of this project is to test the feasibility, acceptability, and efficacy of a treatment module addressing the mental health and functional impact of killing in the war zone.
The investigators will enroll between 12-20 Veterans who have killed in war and have been diagnosed with post-traumatic stress disorder (PTSD) for a pilot study assessing the efficacy of the six-session treatment. Veterans will be randomized either to the treatment or to the waitlist control group.
|Condition or disease||Intervention/treatment|
|Posttraumatic Stress Disorder (PTSD)||Behavioral: Impact of Killing CBT Treatment|
|Study Type :||Observational|
|Actual Enrollment :||8 participants|
|Observational Model:||Case Control|
|Official Title:||Treatment for the Mental Health Impact of Killing in War: Augmentation of Existing Evidence-Based Mental Health Interventions|
|Study Start Date :||October 2011|
|Primary Completion Date :||June 2013|
|Study Completion Date :||June 2013|
Behavioral: Impact of Killing CBT Treatment
- Change in psychological symptoms as measured by the Symptom Checklist-90 (SCL-90-R) [ Time Frame: Measured at baseline and study completion (week 7) ]A brief multidimensional self-report inventory that screens for nine symptoms of psychopathology and provides three global distress indicators.
- Change in killing-related maladaptive cognitions as measured by the Killing Cognitions Scale (KCS) [ Time Frame: Measured at baseline and study completion (week 7) ]Assesses killing-related maladaptive cognitions
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01406834
|United States, California|
|San Francisco VA Medical Center|
|San Francisco, California, United States, 94121|
|Principal Investigator:||Shira Maguen, PhD||University of California San Francisco/ San Francisco VA Medical Center|